32 studies found for:    "Encephalitis, Tick-Borne"
Show Display Options
Rank Status Study
1 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
2 Active, not recruiting Tick-Borne Encephalitis (TBE) Seropersistence After First Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)
Condition: Encephalitis, Tick-Borne
Intervention: Biological: FSME-IMMUN 0.25 mL Junior (1.2 µg TBE antigen/0.25 mL) or FSME-IMMUN 0.5 mL (2.4µg TBE antigen/0.5 mL)
3 Completed An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE
Condition: Tick Borne Encephalitis (TBE)
Intervention: Other: Serology blood draw
4 Completed Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
Condition: Tick-Borne Encephalitis
Interventions: Biological: LGT(TP21)/DEN4;   Biological: Placebo
5 Completed TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
6 Active, not recruiting Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules
Condition: Tick Borne Encephalitis
Intervention: Other: Blood Sampling
7 Active, not recruiting Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac
Condition: Tick-Borne Encephalitis
Intervention: Drug: TicoVac
8 Completed Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
9 Completed TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
10 Unknown  Humoral Response to Tick-borne Encephalitis Vaccine in Elderly
Condition: Tick-borne Encephalitis
Intervention: Biological: FSME-immune
11 Completed Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination
Condition: Tick-borne Encephalitis
Intervention: Biological: TBE vaccination and influenza vaccination
12 Unknown  Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine
Condition: Tick Borne Encephalitis
Intervention: Biological: FSME vaccination (FSME-Immun)
13 Completed Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
14 Completed Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
15 Completed Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
16 Completed FSME IMMUN NEW Follow-Up to Study 208 in Volunteers Aged 16 to 66 Years
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
17 Completed Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
18 Recruiting Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients
Condition: Tick Borne Encephalitis
Intervention: Biological: TBE virus vaccine
19 Active, not recruiting TBE Seropersistence up to 10 Years After First Booster in Adults
Condition: Tick-borne Encephalitis (TBE)
Intervention: Biological: FSME-IMMUN 0.5 ml
20 Completed Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis vaccine

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Indicates status has not been verified in more than two years